0.2115

0.67% 0.0014

Processa Pharmaceuticals Inc (PCSA)

Overview News Price History Financials Discussions Forecast Stock Split

Processa Pharmaceuticals Inc stock is traded at $0.2115, with a volume of 3.90M. It is up +0.67% in the last 24 hours and up +5.75% over the past month. Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Previous Close:

$0.2101

Open:

$0.2092

24h Volume:

3.90M

Relative Volume:

0.23

Market Cap:

$2.51M

Revenue:

Net Income/Loss:

$-11.53M

P/E Ratio:

-0.0439

EPS:

-4.82

Net Cash Flow:

$-11.12M

1W Performance:

-12.89%

1M Performance:

+5.75%

6M Performance:

-67.46%

1Y Performance:

-89.88%

1-Day Range:

$0.203

$0.2179

1-Week Range:

$0.203

$0.24

52-Week Range:

$0.15

$2.12

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name

Processa Pharmaceuticals Inc

Sector

Healthcare (1164)

Industry

Biotechnology (649)

Phone

443-776-3133

Address

7380 COCA COLA DRIVE, HANOVER

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

PCSA's Discussions on Twitter

Compare PCSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PCSA Processa Pharmaceuticals Inc	0.2115	5.50M	0	-11.53M	-11.12M	-4.82
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	673.80	41.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-24	Initiated	H.C. Wainwright	Buy

Processa Pharmaceuticals Inc Stock (PCSA) Latest News

02:51 AM

Using data tools to time your Processa Pharmaceuticals Inc. exitSummary of Trade Cycles in 5-Year Range - Newser

02:51 AM

Aug 01, 2025

Chart based analysis of Processa Pharmaceuticals Inc. trendsDaily Technical Forecast for Quick Gains - Newser

Aug 01, 2025

Multi factor analysis applied to Processa Pharmaceuticals Inc.AI Generated Buy/Sell Signal Forecast - Newser

Aug 01, 2025

What are the technical indicators suggesting about Processa Pharmaceuticals Inc.Free Stock Target Finder That Work - jammulinksnews.com

Aug 01, 2025

Volatility clustering patterns for Processa Pharmaceuticals Inc.Stock Market Trend and Pattern Analysis - Newser

Aug 01, 2025

What are analysts’ price targets for Processa Pharmaceuticals Inc. in the next 12 monthsReal Time Guidance For 2025 - jammulinksnews.com

Aug 01, 2025

Jul 31, 2025

Will Processa Pharmaceuticals Inc. outperform the marketPattern Recognition Based Market Move Prediction - Newser

Jul 31, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityBuy Signal Forecast With Short-Term Data - Newser

Jul 31, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyBreakout Stocks Updates With Proven Results - jammulinksnews.com

Jul 31, 2025

Does Processa Pharmaceuticals Inc. stock perform well during market downturnsExpert Picks Forecasts Backed By Experts - jammulinksnews.com

Jul 31, 2025

Real time breakdown of Processa Pharmaceuticals Inc. stock performanceWatchlist Summary for Active Day Traders - Newser

Jul 31, 2025

Top Risks to Consider Before Buying Processa Pharmaceuticals Inc. StockFree Oversold Recovery Opportunity Stocks - Newser

Jul 31, 2025

Institutional scanner results for Processa Pharmaceuticals Inc.Intraday Movement Recap and Chart Summary - Newser

Jul 31, 2025

Why Processa Pharmaceuticals Inc. is moving todayAI Powered Stock Market Trend Forecast - Newser

Jul 31, 2025

Jul 30, 2025

How Efficient Is Processa Pharmaceuticals Inc. at Controlling Operating CostsTrade Scanner With Buy Zone Alerts Flagged - metal.it

Jul 30, 2025

How to track smart money flows in Processa Pharmaceuticals Inc.Short-Term AI-Based Stock Price Forecast - Newser

Jul 30, 2025

Jul 29, 2025

When is Processa Pharmaceuticals Inc. stock expected to show significant growthBest Dividend Tracker For Every Investor - jammulinksnews.com

Jul 29, 2025

Is Processa Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideTrade Flow Monitor with Volume Tracker - Newser

Jul 29, 2025

Jul 28, 2025

Using data tools to time your Processa Pharmaceuticals Inc. exit Free Fundamental Growth Stock Analysis - Newser

Jul 28, 2025

How does Processa Pharmaceuticals Inc. compare to its industry peersUncover the best stocks for explosive growth - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Is Processa Pharmaceuticals Inc. stock overvalued or undervaluedMaximize gains with timely market signals - jammulinksnews.com

Jul 27, 2025

What catalysts could drive Processa Pharmaceuticals Inc. stock higher in 2025Superior capital gains - jammulinksnews.com

Jul 27, 2025

Published on: 2025-07-28 04:57:21 - jammulinksnews.com

Jul 27, 2025

Published on: 2025-07-28 02:01:14 - jammulinksnews.com

Jul 27, 2025